language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
HIMSHIMS

$14.52

-1.08
arrow_drop_down6.92%
Market closed·update27 Feb 2026 21:00

$14.55

+0.03
arrow_drop_up0.21%
Post-market·update28 Feb 2026 00:59
Day's Range
14.48-15.2915
52-week Range
13.74-70.43

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2026-02-23
Next Earnings TimeAfter Market Close
Volume23.34M
Average Volume 30d22.98M

AI HIMS Summary

Powered by LiveAI
💰
84.29
Valuation (P/E Ratio)
High for industry, but reflects growth potential
📈
0.152
EPS Growth (YoY)
Strong earnings growth
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
78

Hims & Hers Health shows strong recent growth and improving profitability, supported by positive thematic trends in digital health. However, valuation metrics are high, and technical indicators suggest some short-term caution.

Strong

Thematic

75

Hims & Hers is well-positioned in the growing telehealth and personalized wellness sectors, benefiting from increased consumer adoption of digital health solutions.

Strong

Fundamental

85

Hims & Hers shows strong revenue growth and a positive turnaround in profitability, with a solid balance sheet and improving cash flow generation.

Bullish

Technical

73

The stock has shown strong recent performance, but some indicators suggest it may be approaching overbought territory, hinting at potential for a short-term pause or retracement.

FactorScore
Digital Health Adoption85
Personalized Wellness Market70
Subscription Model Strength78
Competitive Landscape65
Regulatory Environment72
FactorScore
Valuation50
Profitability70
Growth95
Balance Sheet Health85
Cash Flow90
FactorScore
Trend Analysis80
Momentum65
Volume Confirmation75
Support & Resistance70
Short-Term Indicators80

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (6)

Earnings Performance chevron_right

Consistent EPS Beat

The company has exceeded earnings per share (EPS) estimates for the last 4 consecutive quarters, indicating strong operational execution and profitability.

Valuation chevron_right

Growth Exceeds P/E

The trailing P/E ratio of 84.29 is high, but the consistent EPS growth suggests potential justification. The company's focus on expanding services and market reach may support this valuation.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation Risk chevron_right

High P/E Ratio

The trailing P/E ratio of 84.29 is significantly higher than historical averages and industry peers, suggesting potential overvaluation and a higher risk of price correction.

Profitability & Margins chevron_right

Negative Net Margins in Prior Years

While current net margins are positive, the company experienced negative net margins in 2023, 2022, and 2021, indicating historical profitability challenges.

Show More 🔒

Calendar

August 2025

5

Next Earnings Date

EPS Est.
Revenue Est.

H: $0.27

A: $0.22

L: $0.18

H: 563.59M

A: 551.30M

L: 540.01M

Profile

Websitehims.com
Employees (FY)1.64K
ISINUS4330001060
FIGI-

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Seasonals

2025
2024
2023
2022
2021

Price Target

49.20 USD

The 39 analysts offering 1 year price forecasts for HIMS have a max estimate of 85.00 and a min estimate of 28.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
195M (90.32%)
Closely held shares
20.9M (9.68%)
215M
Free Float shares
195M (90.32%)
Closely held shares
20.9M (9.68%)

Capital Structure

Market cap
12.35B
Debt
11.35M
Minority interest
0.00
Cash & equivalents
220.58M
Enterprise value
12.14B

Valuation - Summary

Market Cap
12.8B
Net income
151M(1.18%)
Revenue
1.47B(11.45%)
12.8B
Market Cap
12.8B
Net income
151M(1.18%)
Revenue
1.47B(11.45%)
Price to earning ratio (P/E)84.90x
Price to sales ratio (P/S)8.70x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
1.48B
COGS
303.38M
Gross Profit
1.17B
OpEx
1.11B
Operating Income
61.9M
Other & Taxes
-64.14M
Net Income
126.04M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒